Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Biliary fibrosis is crucial in liver diseases and understanding it can help prevent and treat these conditions.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Asiasari radix extract may be a potential treatment for melanoma because it selectively triggers cell death in melanoma cells by affecting p53 regulation.

Cyclosporine combined with other treatments can help hair regrow in severe alopecia areata, but it may cause side effects.

Kerion is a rare but serious scalp infection that needs proper treatment.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Excessive selenium intake can cause liver damage.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

A new engineered treatment shows promise in curing heart fibrosis.

Reporter characteristics affect detection of hair loss from cancer therapy.

High mTORC1 activity slows hair growth and causes it to lose color.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

mTOR inhibitors may help treat lung fibrosis.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Upadacitinib effectively treated severe hair loss in a child.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.